Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Israeli IBD Research Nucleus (IIRN) Consortium: COBMINDEX Goes Forward- A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease

NCT06221254 is registered in ClinicalTrials.gov with Soroka University Medical Center as lead sponsor.

NCT NCT06221254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06221254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Israeli IBD Research Nucleus (IIRN) Consortium: COBMINDEX Goes Forward- A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease
Lead sponsor
Soroka University Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
August 1, 2023
Completion date
August 1, 2027
Enrollment
200 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease